CoChat

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations

Open access
Jing, Hua, Kase, Julia, Dörr, Jan R., Milanovic, Maja, Lenze, Dido, Grau, Michael, Beuster, Gregor, Ji, Sujuan, Reimann, Maurice, Lenz, Peter, Hummel, Michael, Dörken, Bernd, Lenz, Georg, Scheidereit, Claus, Schmitt, Clemens A., Lee, Soyoung · 2011 · Genes & Development
Cited by 99

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

In malignancies, enhanced nuclear factor-κB (NF-κB) activity is largely viewed as an oncogenic property that also confers resistance to chemotherapy. Recently, NF-κB has been postulated to participate in a senescence-associated and possibly senescence-reinforcing cytokine response, thereby suggesting a tumor-restraining role for NF-κB. Using a mouse lymphoma model and analyzing transcriptome and clinical data from lymphoma patients, we show here that therapy-induced senescence presents with and depends on active NF-κB signaling, whereas NF-κB simultaneously promotes resistance to apoptosis. Further characterization and genetic engineering of primary mouse lymphomas according to distinct NF-κB-related oncogenic networks reminiscent of diffuse large B-cell lymphoma (DLBCL) subtypes guided us to identify Bcl2-overexpressing germinal center B-cell-like (GCB) DLBCL as a clinically relevant subgroup with significantly superior outcome when NF-κB is hyperactive. Our data illustrate the power of cross-species investigations to functionally test genetic mechanisms in transgenic mouse tumors that recapitulate distinct features of the corresponding human entity, and to ultimately use the mouse model-derived genetic information to redefine novel, clinically relevant patient subcohorts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.17620611

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 34

  1. 10.1038/318533a0 · DOI · Paper page
  2. 10.1182/blood-2010-09-297879 · DOI · Paper page
  3. 10.1038/ni.2060 · DOI · Paper page
  4. 10.1172/JCI115354 · DOI · Paper page
  5. 10.1074/jbc.M409825200 · DOI · Paper page
  6. 10.1016/j.ccr.2010.11.024 · DOI · Paper page
  7. 10.1038/nature07968 · DOI · Paper page
  8. 10.1084/jem.194.12.1861 · DOI · Paper page
  9. 10.1073/pnas.92.20.9363 · DOI · Paper page
  10. 10.1182/blood-2009-01-199679 · DOI · Paper page
  11. 10.1182/blood-2004-12-4901 · DOI · Paper page
  12. 10.1074/jbc.272.39.24113 · DOI · Paper page
  13. 10.1016/j.cell.2008.01.020 · DOI · Paper page
  14. 10.1056/NEJM199309303291402 · DOI · Paper page
  15. 10.1200/JCO.2005.03.4264 · DOI · Paper page
  16. 10.1186/1471-2407-10-348 · DOI
  17. 1996, Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo, EMBO J, 15, 6716, 10.1002/j.1460-2075.1996.tb01061.x · DOI · Paper page
  18. 10.1126/science.1153629 · DOI · Paper page
  19. 10.1056/NEJMoa0802885 · DOI · Paper page
  20. 2010, Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy, Biochim Biophys Acta, 1805, 167
  21. 10.1016/j.ccr.2006.12.016 · DOI · Paper page
  22. 10.1038/nature04687 · DOI · Paper page
  23. 10.1200/JCO.2010.33.3252 · DOI · Paper page
  24. 10.1182/blood-2007-02-075614 · DOI · Paper page
  25. 10.1038/onc.2010.611 · DOI · Paper page
  26. 10.1200/JCO.2010.31.1142 · DOI · Paper page
  27. 10.1038/35009130 · DOI · Paper page
  28. 10.1038/79542 · DOI · Paper page
  29. 10.1093/jnci/djn174 · DOI
  30. 10.1016/0092-8674(86)90346-6 · DOI · Paper page
  31. 10.1111/j.0105-2896.2006.00373.x · DOI · Paper page
  32. 10.1126/science.281.5383.1680 · DOI · Paper page
  33. 10.1038/7410 · DOI · Paper page
  34. 10.1172/JCI42358 · DOI · Paper page

Cited by

See all 99

Metadata

Authors
Jing, H., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., Hummel, M., Dörken, B., Lenz, G., Scheidereit, C., Schmitt, C. A., & Lee, S.
Venue
Genes & Development
Published
2011-10-06
Volume
25
Issue
20
Pages
2137-2146
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2163924431
Cited by
99
References
20
Type
posted content
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. https://app.cochat.ai/papers/10.1101/gad.17620611
The paper
Jing, H., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., Hummel, M., Dörken, B., Lenz, G., Scheidereit, C., Schmitt, C. A., & Lee, S. (2011). Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. Genes & Development. https://doi.org/10.1101/gad.17620611

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.